Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice. [electronic resource]
- Life sciences Jul 2019
- 266-273 p. digital
Publication Type: Journal Article
1879-0631
10.1016/j.lfs.2019.05.019 doi
Animals Anti-Inflammatory Agents--therapeutic use Antioxidants--therapeutic use Chemical and Drug Induced Liver Injury--drug therapy Dipeptidyl-Peptidase IV Inhibitors--therapeutic use Liver--drug effects Male Mice NF-kappa B--immunology Oxidative Stress--drug effects Signal Transduction--drug effects Sitagliptin Phosphate--therapeutic use Thioacetamide--adverse effects Toll-Like Receptor 4--immunology